Proto Labs, Inc. (PRLB) Guidance & Earnings Results

On 2026-07-31 Proto Labs, Inc. raised guidance: "FY26 revenue growth raised to 8%-10% from 6%-8%; Q3 2026 revenue $145.0M-$153.0M; Q3 2026 GAAP diluted EPS $0.34-$0.42; Q3 2026 non-GAAP diluted EPS…" — from its own filing, as read by EquiReason.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

PRLBProto Labs, Inc.Follow PRLB — free

Metal Fabrication · Industrials

—

Price chart with a free account

Market cap: 2.0B
P/E TTM: 68.5
Dividend yield: —
52-week: —
Next earnings: 29 Oct, in 5 days

What management guided

each earnings 8-K · figures checked against the filing text

Release	Direction	What they said
31 Jul 26	Raised	FY26 revenue growth raised to 8%-10% from 6%-8%; Q3 2026 revenue $145.0M-$153.0M; Q3 2026 GAAP diluted EPS $0.34-$0.42; Q3 2026 non-GAAP diluted EPS $0.56-$0.64 · full year
1 May 26	Raised	FY2026 revenue growth 6-8%; Q2 2026 revenue $140-148M; Q2 2026 non-GAAP EPS $0.50-$0.58 · full year
6 Feb 26	Raised	FY2026 revenue growth 6-8%; Q1 2026 revenue $130M-$138M · full year
31 Oct 25	Reaffirmed	Q4 revenue guidance $125M-$133M
31 Jul 25	Reaffirmed	Q3 2025 revenue $130.0-138.0M; GAAP diluted EPS $0.17-0.25; non-GAAP diluted EPS $0.35-0.43

Proto Labs, Inc. — questions

What guidance did Proto Labs, Inc. give?: On 2026-07-31: "FY26 revenue growth raised to 8%-10% from 6%-8%; Q3 2026 revenue $145.0M-$153.0M; Q3 2026 GAAP diluted EPS $0.34-$0.42; Q3 2026 non-GAAP diluted EPS $0.56-$0.64"
When does Proto Labs, Inc. report earnings?: Proto Labs, Inc.'s next earnings report is expected on 2026-10-29.

Every figure on this page comes from Proto Labs, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.